This
report presents detailed analysis of the STD market in the US, Europe
(France, Germany, Italy, Spain, UK) and Japan. Current scientific views on
epidemiology and etiology are presented for Chancroid, Chlamydia, Gonorrhea,
Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report
provides test volume and sales forecasts by country and market segment,
including:
- Hospitals
- Commercial/Private Labs
- Physician Offices
- Public Health Labs
In
addition to test volume and sales projections, the report presents sales and
market share estimates for major suppliers of STD diagnostic products, by test
and country. Also, the report:
- Examines market applications of Molecular Diagnostics,
- Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;
- Reviews features and operating characteristics of major analyzers used for STD testing;
- Profiles key suppliers and potential market entrants developing innovative technologies and products; and
- Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.
Methodology
The
report is based on a combination of primary and secondary information sources,
including interviews with laboratory directors, and executives of leading
diagnostics companies and start-up firms developing innovative products in the
U.S., five major European countries and Japan.
In
addition to primary sources of information, a comprehensive review of the most
recent technical and business publications, manufacturer product and financial
literature, as well as Venture Planning Group’s proprietary data files was
conducted.
Buy your report copy @ http://www.rnrmarketresearch.com/contacts/purchase?rname=65084
No comments:
Post a Comment